Article
Genetic Variants Associated With Opioid Use Disorder
6 Feb 2023
Abstract excerpt
Genetics are presumed to contribute 30-40% to opioid use disorder (OUD), allowing for the possibility that genetic markers could be used to identify personal risk for developing OUD. We aimed to test the potential association among 180 candidate single nucleotide polymorphisms (SNPs), 120 of which were related to the dopamine reward pathway and 60 related to pharmacokinetics. Participants were randomly recruited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
